Preferential expansion of human virus-specific multifunctional central memory T cells by partial targeting of the IL-2 receptor signaling pathway: The key role of CD4 + T cells

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 5189-5198

  Schmueck, Michael ^a   Fischer, Annika M ^a   Hammoud, Ben ^a   Brestrich, Gordon ^a   Fuehrer, Henrike ^a   Luu, Si Hong ^a   Mueller, Karin ^a   Babel, Nina ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL EXPANSION; CELL FUNCTION; CELL THERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOSTIMULATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TOR SERINE-THREONINE KINASES;

EID: 84861167386     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103763     Document Type: Article

References (39)

1. Brestrich, G., S. Zwinger, A. Fischer, M. Schmuck, A. Rohmhild, M. H. Hammer, A. Kurtz, L. Uharek, C. Knosalla, H. Lehmkuhl, et al. 2009. Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy. Am. J. Transplant. 9: 1679-1684.
2. Kaech, S. M., and E. J. Wherry. 2007. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27: 393-405. (Pubitemid 47418674)
3. Grupp, S. A., and C. H. June. 2011. Adoptive cellular therapy. Curr. Top. Microbiol. Immunol. 344: 149-172.
4. Fujita, Y., C. M. Rooney, and H. E. Heslop. 2008. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant. 41: 193-198. (Pubitemid 351188917)
5. Shaffer, D. R., C. M. Rooney, and S. Gottschalk. 2010. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation. Immunotherapy 2: 663-671.
6. Savoldo, B., J. A. Goss, M. M. Hammer, L. Zhang, T. Lopez, A. P. Gee, Y. F. Lin, R. E. Quiros-Tejeira, P. Reinke, S. Schubert, et al. 2006. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 108: 2942-2949.
7. Hammer, M. H., S. Meyer, G. Brestrich, A. Moosmann, F. Kern, L. Tesfa, N. Babel, A. Mittenzweig, C. M. Rooney, W. Hammerschmidt, et al. 2005. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy. Eur. J. Immunol. 35: 2250-2258. (Pubitemid 41015064)
8. Haque, T., G. M. Wilkie, M. M. Jones, C. D. Higgins, G. Urquhart, P. Wingate, D. Burns, K. McAulay, M. Turner, C. Bellamy, et al. 2007. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 110: 1123-1131. (Pubitemid 47281407)
9. Razonable, R. R., A. Rivero, A. Rodriguez, J. Wilson, J. Daniels, G. Jenkins, T. Larson, W. C. Hellinger, J. R. Spivey, and C. V. Paya. 2001. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J. Infect. Dis. 184: 1461-1464. (Pubitemid 33108862)
10. Tussey, L., S. Speller, A. Gallimore, and R. Vessey. 2000. Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J. Immunol. 30: 1823-1829. (Pubitemid 30456178)
11. Berger, C., M. C. Jensen, P. M. Lansdorp, M. Gough, C. Elliott, and S. R. Riddell. 2008. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118: 294-305.
12. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
13. Wang, X., C. Berger, C. W. Wong, S. J. Forman, S. R. Riddell, and M. C. Jensen. 2011. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice. Blood 117: 1888-1898.
14. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
15. Araki, K., B. Youngblood, and R. Ahmed. 2010. The role of mTOR in memory CD8 T-cell differentiation. Immunol. Rev. 235: 234-243.
16. Turner, A. P., V. O. Shaffer, K. Araki, C. Martens, P. L. Turner, S. Gangappa, M. L. Ford, R. Ahmed, A. D. Kirk, and C. P. Larsen. 2011. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am. J. Transplant. 11: 613-618.
17. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124: 471-484. (Pubitemid 43199434)
18. Mariotti, J., J. Foley, U. Jung, T. Borenstein, N. Kantardzic, S. Han, J. T. Hanson, E. Wong, N. Buxhoeveden, J. B. Trepel, et al. 2008. Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection. J. Immunol. 180: 89-105.
19. Rao, R. R., Q. Li, K. Odunsi, and P. A. Shrikant. 2010. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32: 67-78.
20. Brestrich, G., S. Zwinger, A. Roemhild, M. Noutsias, M. Rohde, K. Keeren, B. Sawitzki, H. D. Volk, P. Reinke, and M. H. Hammer. 2009. Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy. J. Immunother. 32: 932-940.
21. Hermans, I. F., J. D. Silk, J. Yang, M. J. Palmowski, U. Gileadi, C. McCarthy, M. Salio, F. Ronchese, and V. Cerundolo. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods 285: 25-40. (Pubitemid 38186583)
22. Raftery, M. J., M. Hitzler, F. Winau, T. Giese, B. Plachter, S. H. Kaufmann, and G. Schönrich. 2008. Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 82: 4308-4319. (Pubitemid 351563668)
23. Becker, C., H. Pohla, B. Frankenberger, T. Schüler, M. Assenmacher, D. J. Schendel, and T. Blankenstein. 2001. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Nat. Med. 7: 1159-1162. (Pubitemid 33010027)
24. Precopio, M. L., M. R. Betts, J. Parrino, D. A. Price, E. Gostick, D. R. Ambrozak, T. E. Asher, D. C. Douek, A. Harari, G. Pantaleo, et al. 2007. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204: 1405-1416. (Pubitemid 46919878)
25. Sehgal, S. N. 1998. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin. Biochem. 31: 335-340. (Pubitemid 28385231)
26. Janssen, E. M., E. E. Lemmens, T. Wolfe, U. Christen, M. G. von Herrath, and S. P. Schoenberger. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421: 852-856. (Pubitemid 36254145)
27. Gerna, G., F. Baldanti, and M. G. Revello. 2004. Pathogenesis of human cytomegalovirus infection and cellular targets. Hum. Immunol. 65: 381-386. (Pubitemid 38686760)
28. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234. (Pubitemid 36322131)
29. He, S., K. Kato, J. Jiang, D. R. Wahl, S. Mineishi, E. M. Fisher, D. M. Murasko, G. D. Glick, and Y. Zhang. 2011. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. PLoS ONE 6: e20107.
30. Pearce, E. L., M. C. Walsh, P. J. Cejas, G. M. Harms, H. Shen, L. S. Wang, R. G. Jones, and Y. Choi. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
31. Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17: 326-332. (Pubitemid 40692670)
32. Monti, P., C. Brigatti, A. K. Heninger, M. Scirpoli, and E. Bonifacio. 2009. Disengaging the IL-2 receptor with daclizumab enhances IL-7-mediated proliferation of CD4(+) and CD8(+) T cells. Am. J. Transplant. 9: 2727-2735.
33. Sun, J. C., M. A. Williams, and M. J. Bevan. 2004. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat. Immunol. 5: 927-933. (Pubitemid 39276237)
34. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950. (Pubitemid 26234507)
35. Brown, D. M. 2010. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell. Immunol. 262: 89-95.
36. Ho, W. Y., C. Yee, and P. D. Greenberg. 2002. Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. J. Clin. Invest. 110: 1415-1417.
37. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241.
38. Brown, D. M., C. Kamperschroer, A. M. Dilzer, D. M. Roberts, and S. L. Swain. 2009. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell. Immunol. 257: 69-79.
39. Le Borgne, M., N. Etchart, A. Goubier, S. A. Lira, J. C. Sirard, N. van Rooijen, C. Caux, S. Aït-Yahia, A. Vicari, D. Kaiserlian, and B. Dubois. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24: 191-201. (Pubitemid 43214588)